Enhancing Hepatitis C Testing And Treatment Among People Who Inject Drugs In Drug Treatment Settings: The ETHOS III Study
Funder
National Health and Medical Research Council
Funding Amount
$1,349,604.00
Summary
Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.
I-HEART - Implementation Of HEArt Failure Guidelines In Regional AusTralia
Funder
National Health and Medical Research Council
Funding Amount
$1,266,173.00
Summary
Heart failure (HF) is a common disease of the heart with a high rehospitalisation and mortality rate. Regional HF patients rarely receive the full benefits of evidence-based care simply due to inaccessibility to a HF specialist team. This translational project will implement key recommendations from clinical guidelines in regional health services and improve access to specialist services. It has the potential to keep patients out of hospital and save lives.